Puration Confirms Plans To Apply For Canadian Recreational Cannabis Cultivation License

Puration Confirms Plans To Apply For Canadian Recreational Cannabis Cultivation License

Dallas, TX -- May 14, 2018 -- InvestorsHub NewsWire -- Puration, Inc. (USOTC: PURA) today confirmed plans to apply for a recreational cannabis cultivation license in Canada. Last week the company announced the acquisition of Canadian Cannabis Farmers Co-Op to position Puration for the recreational marijuana market expected to be legalized nationwide in Canada this summer. The company followed up the acquisition with an online presentation on the company’s overall cannabis cultivation business operation and plans for the future.

“Today, Puration has two separate, but related business operations,” explained CEO Brian Shibley. “The company produces and sells the leading CBD infused beverage in the nutritional sports supplement market under the brand name EVERx. The company also entered the cannabis cultivation market with a long-term strategy through the acquisition last year of First Choice Nursery. First Choice Nursery’s sales have contributed to Puration’s overall sales in the first quarter of this year, 2018, by adding to the existing sales of EVERx. We have comprehensive initiatives underway to grow both the beverage business and the cultivation business by tapping into Canada’s legalization of recreational marijuana. We have a new THC infused beverage for Canada and we have acquired a business that comes with substantial experience in Canada’s medical marijuana cultivation market that we believe will be invaluable to us in pursuing Canada’s recreational marijuana cultivation market. Yes, Puration plans to apply for a recreational cannabis cultivation license in Canada.”

For more information on Puration, visit http://www.aciconglomerated.com.

Disclaimer/Safe Harbor:
This news release contains forward-looking statements within the meaning of the Securities Litigation Reform Act. The statements reflect the Company's current views with respect to future events that involve risks and uncertainties. Among others, these risks include the expectation that any of the companies mentioned herein will achieve significant sales, the failure to meet schedule or performance requirements of the companies' contracts, the companies' liquidity position, the companies' ability to obtain new contracts, the emergence of competitors with greater financial resources and the impact of competitive pricing. In the light of these uncertainties, the forward-looking events referred to in this release might not occur. These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease.

Puration, Inc.
Brian Shibley,
info@aciconglomerated.com
+1-800-861-1350